{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T00:28:51Z","timestamp":1794011331856,"version":"4.8.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T00:00:00Z","timestamp":1619568000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T00:00:00Z","timestamp":1619568000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["211085\/Z\/18\/Z"],"award-info":[{"award-number":["211085\/Z\/18\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["101143\/Z\/13\/Z"],"award-info":[{"award-number":["101143\/Z\/13\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/N013867\/1"],"award-info":[{"award-number":["MR\/N013867\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Lithium is the most effective treatment in bipolar disorder. Its use is limited by concerns about risk of chronic kidney disease (CKD). We aimed to develop a model to predict risk of CKD following lithium treatment initiation, by identifying individuals with a high-risk trajectory of kidney function.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We used United Kingdom Clinical Practice Research Datalink (CPRD) electronic health records (EHRs) from 2000 to 2018. CPRD Aurum for prediction model development and CPRD Gold for external validation. We used elastic net regularised regression to generate a prediction model from potential features. We performed discrimination and calibration assessments in an external validation data set.<\/jats:p>\n                    <jats:p>\n                      We included all patients aged \u2265\u200916 with bipolar disorder prescribed lithium. To be included patients had to have \u2265\u20091\u2009year of follow-up before lithium initiation, \u2265\u20093 estimated glomerular filtration rate (eGFR) measures after lithium initiation (to be able to determine a trajectory) and a normal (\u2265\u200960\u2009mL\/min\/1.73\u00a0m\n                      <jats:sup>2<\/jats:sup>\n                      ) eGFR at lithium initiation (baseline). In the Aurum development cohort, 1609 fulfilled these criteria. The Gold external validation cohort included 934 patients.\n                    <\/jats:p>\n                    <jats:p>We included 44 potential baseline features in the prediction model, including sociodemographic, mental and physical health and drug treatment characteristics. We compared a full model with the 3-variable 5-year kidney failure risk equation (KFRE) and a 3-variable elastic net model.<\/jats:p>\n                    <jats:p>We used group-based trajectory modelling to identify latent trajectory groups for eGFR. We were interested in the group with deteriorating kidney function (the high-risk group).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The high risk of deteriorating eGFR group included 191 (11.87%) of the Aurum cohort and 137 (14.67%) of the Gold cohort. Of these, 168 (87.96%) and 117 (85.40%) respectively developed CKD 3a or more severe during follow-up. The model, developed in Aurum, had a ROC area of 0.879 (95%CI 0.853\u20130.904) in the Gold external validation data set. At the empirical optimal cut-point defined in the development dataset, the model had a sensitivity of 0.91 (95%CI 0.84\u20130.97) and a specificity of 0.74 (95% CI 0.67\u20130.82). However, a 3-variable elastic net model (including only age, sex and baseline eGFR) performed similarly well (ROC area 0.888; 95%CI 0.864\u20130.912), as did the KFRE (ROC area 0.870; 95%CI 0.841\u20130.898).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Individuals at high risk of a poor eGFR trajectory can be identified before initiation of lithium treatment by a simple equation including age, sex and baseline eGFR. Risk was increased in individuals who were younger at commencement of lithium, female and had a lower baseline eGFR. We did not identify strong predicters of eGFR decline specific to lithium-treated patients. Notably, lithium duration and toxicity were not associated with high-risk trajectory.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12916-021-01964-z","type":"journal-article","created":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T21:09:28Z","timestamp":1619557768000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Prediction of individuals at high risk of chronic kidney disease during treatment with lithium for bipolar disorder"],"prefix":"10.1186","volume":"19","author":[{"given":"Joseph F.","family":"Hayes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P. J.","family":"Osborn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Francis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gareth","family":"Ambler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie A.","family":"Tomlinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"Boman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian C. K.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Geddes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Dalman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glyn","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,28]]},"reference":[{"key":"1964_CR1","doi-asserted-by":"crossref","unstructured":"Barroilhet SA, Ghaemi SN. When and how to use lithium. Acta Psychiatrica Scandinavica. 2020;142(3):161\u201372.","DOI":"10.1111\/acps.13202"},{"issue":"1","key":"1964_CR2","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s40345-019-0151-2","volume":"7","author":"L Tondo","year":"2019","unstructured":"Tondo L, Alda M, Bauer M, Bergink V, Grof P, Hajek T, et al. Clinical use of lithium salts: guide for users and prescribers. Int J Bipolar Disorders. 2019;7(1):16. https:\/\/doi.org\/10.1186\/s40345-019-0151-2.","journal-title":"Int J Bipolar Disorders."},{"issue":"1","key":"1964_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40345-016-0068-y","volume":"4","author":"M Gitlin","year":"2016","unstructured":"Gitlin M. Lithium side effects and toxicity: prevalence and management strategies. Int J Bipolar Disorders. 2016;4(1):1\u201310.","journal-title":"Int J Bipolar Disorders"},{"issue":"9817","key":"1964_CR4","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/S0140-6736(11)61516-X","volume":"379","author":"RF McKnight","year":"2012","unstructured":"McKnight RF, Adida M, Budge K, Stockton S, Goodwin GM, Geddes JR. Lithium toxicity profile: a systematic review and meta-analysis. Lancet. 2012;379(9817):721\u20138. https:\/\/doi.org\/10.1016\/S0140-6736(11)61516-X.","journal-title":"Lancet"},{"key":"1964_CR5","doi-asserted-by":"crossref","unstructured":"Hayes JF, Marston L, Walters K, Geddes JR, King M, Osborn DP. Adverse renal, endocrine, hepatic, and metabolic events during maintenance mood stabilizer treatment for bipolar disorder: a population-based cohort study. PLoS medicine. 2016;13(8):e1002058.","DOI":"10.1371\/journal.pmed.1002058"},{"key":"1964_CR6","doi-asserted-by":"publisher","first-page":"421","DOI":"10.2147\/CLEP.S154841","volume":"10","author":"M Iwagami","year":"2018","unstructured":"Iwagami M, Mansfield KE, Hayes JF, Walters K, Osborn DP, Smeeth L, Nitsch D, Tomlinson L. Severe mental illness and chronic kidney disease: a cross-sectional study in the United Kingdom. Clin Epidemiol. 2018;10:421\u20139. https:\/\/doi.org\/10.2147\/CLEP.S154841.","journal-title":"Clin Epidemiol"},{"issue":"12","key":"1964_CR7","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1001\/jamapsychiatry.2015.1834","volume":"72","author":"LV Kessing","year":"2015","unstructured":"Kessing LV, Gerds TA, Feldt-Rasmussen B, Andersen PK, Licht RW. Use of lithium and anticonvulsants and the rate of chronic kidney disease: a nationwide population-based study. JAMA Psychiatry. 2015;72(12):1182\u201391. https:\/\/doi.org\/10.1001\/jamapsychiatry.2015.1834.","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"1964_CR8","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1192\/pb.bp.116.054031","volume":"41","author":"S Gupta","year":"2017","unstructured":"Gupta S, Khastgir U. Drug information update. Lithium and chronic kidney disease: debates and dilemmas. BJPsych Bull. 2017;41(4):216\u201320. https:\/\/doi.org\/10.1192\/pb.bp.116.054031.","journal-title":"BJPsych Bull"},{"issue":"4","key":"1964_CR9","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/kisup.2013.79","volume":"3","author":"R Kazancio\u011flu","year":"2013","unstructured":"Kazancio\u011flu R. Risk factors for chronic kidney disease: an update. Kidney Int Suppl. 2013;3(4):368\u201371. https:\/\/doi.org\/10.1038\/kisup.2013.79.","journal-title":"Kidney Int Suppl"},{"issue":"2","key":"1964_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0212590","volume":"14","author":"CC Lim","year":"2019","unstructured":"Lim CC, Chee ML, Cheng C-Y, Kwek JL, Foo M, Wong TY, Sabanayagam C. Simplified end stage renal failure risk prediction model for the low-risk general population with chronic kidney disease. PLoS One. 2019;14(2):e0212590. https:\/\/doi.org\/10.1371\/journal.pone.0212590.","journal-title":"PLoS One"},{"key":"1964_CR11","doi-asserted-by":"crossref","unstructured":"Ramspek CL, de Jong Y, Dekker FW, van Diepen M. Towards the best kidney failure prediction tool: a systematic review and selection aid. Nephrology Dialysis Transplantation. 2020;35(9):1527\u201338.","DOI":"10.1093\/ndt\/gfz018"},{"issue":"4","key":"1964_CR12","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1053\/j.ajkd.2008.04.026","volume":"52","author":"ES Johnson","year":"2008","unstructured":"Johnson ES, Thorp ML, Platt RW, Smith DH. Predicting the risk of dialysis and transplant among patients with CKD: a retrospective cohort study. Am J Kidney Dis. 2008;52(4):653\u201360. https:\/\/doi.org\/10.1053\/j.ajkd.2008.04.026.","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"1964_CR13","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1097\/MNH.0b013e328359072f","volume":"21","author":"C Rigatto","year":"2012","unstructured":"Rigatto C, Sood MM, Tangri N. Risk prediction in chronic kidney disease: pitfalls and caveats. Curr Opin Nephrol Hypertens. 2012;21(6):612\u20138. https:\/\/doi.org\/10.1097\/MNH.0b013e328359072f.","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"2","key":"1964_CR14","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1001\/jama.2015.18202","volume":"315","author":"N Tangri","year":"2016","unstructured":"Tangri N, Grams ME, Levey AS, Coresh J, Appel LJ, Astor BC, Chodick G, Collins AJ, Djurdjev O, Elley CR, Evans M, Garg AX, Hallan SI, Inker LA, Ito S, Jee SH, Kovesdy CP, Kronenberg F, Heerspink HJL, Marks A, Nadkarni GN, Navaneethan SD, Nelson RG, Titze S, Sarnak MJ, Stengel B, Woodward M, Iseki K, for the CKD Prognosis Consortium. Multinational assessment of accuracy of equations for predicting risk of kidney failure: a meta-analysis. Jama. 2016;315(2):164\u201374. https:\/\/doi.org\/10.1001\/jama.2015.18202.","journal-title":"Jama."},{"issue":"3","key":"1964_CR15","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1093\/ije\/dyv098","volume":"44","author":"E Herrett","year":"2015","unstructured":"Herrett E, Gallagher AM, Bhaskaran K, Forbes H, Mathur R, Van Staa T, et al. Data resource profile: clinical practice research datalink (CPRD). Int J Epidemiol. 2015;44(3):827\u201336. https:\/\/doi.org\/10.1093\/ije\/dyv098.","journal-title":"Int J Epidemiol"},{"issue":"6","key":"1964_CR16","doi-asserted-by":"publisher","first-page":"1740-g","DOI":"10.1093\/ije\/dyz034","volume":"48","author":"A Wolf","year":"2019","unstructured":"Wolf A, Dedman D, Campbell J, Booth H, Lunn D, Chapman J, et al. Data resource profile: Clinical practice research datalink (cprd) aurum. Int J Epidemiol. 2019;48(6):1740-g.","journal-title":"Int J Epidemiol."},{"issue":"18","key":"1964_CR17","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1001\/jama.2012.3954","volume":"307","author":"K Matsushita","year":"2012","unstructured":"Matsushita K, Mahmoodi BK, Woodward M, Emberson JR, Jafar TH, Jee SH, Polkinghorne KR, Shankar A, Smith DH, Tonelli M, Warnock DG, Wen CP, Coresh J, Gansevoort RT, Hemmelgarn BR, Levey AS, Chronic Kidney Disease Prognosis Consortium. Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. Jama. 2012;307(18):1941\u201351. https:\/\/doi.org\/10.1001\/jama.2012.3954.","journal-title":"Jama."},{"issue":"1","key":"1964_CR18","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1146\/annurev.clinpsy.121208.131413","volume":"6","author":"DS Nagin","year":"2010","unstructured":"Nagin DS, Odgers CL. Group-based trajectory modeling in clinical research. Annu Rev Clin Psychol. 2010;6(1):109\u201338. https:\/\/doi.org\/10.1146\/annurev.clinpsy.121208.131413.","journal-title":"Annu Rev Clin Psychol"},{"issue":"4","key":"1964_CR19","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1080\/10705510701575396","volume":"14","author":"KL Nylund","year":"2007","unstructured":"Nylund KL, Asparouhov T, Muth\u00e9n BO. Deciding on the number of classes in latent class analysis and growth mixture modeling: a Monte Carlo simulation study. Struct Equ Model Multidiscip J. 2007;14(4):535\u201369. https:\/\/doi.org\/10.1080\/10705510701575396.","journal-title":"Struct Equ Model Multidiscip J"},{"issue":"1","key":"1964_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12882-018-1101-4","volume":"19","author":"J Davis","year":"2018","unstructured":"Davis J, Desmond M, Berk M. Lithium and nephrotoxicity: a literature review of approaches to clinical management and risk stratification. BMC Nephrol. 2018;19(1):1\u20137.","journal-title":"BMC Nephrol"},{"issue":"2","key":"1964_CR21","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/j.1467-9868.2005.00503.x","volume":"67","author":"H Zou","year":"2005","unstructured":"Zou H, Hastie T. Regularization and variable selection via the elastic net. J Royal Statistical Society: Series B (Stat Methodol). 2005;67(2):301\u201320. https:\/\/doi.org\/10.1111\/j.1467-9868.2005.00503.x.","journal-title":"J Royal Statistical Society: Series B (Stat Methodol)"},{"issue":"15","key":"1964_CR22","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1001\/jama.2011.451","volume":"305","author":"N Tangri","year":"2011","unstructured":"Tangri N, Stevens LA, Griffith J, Tighiouart H, Djurdjev O, Naimark D, Levin A, Levey AS. A predictive model for progression of chronic kidney disease to kidney failure. Jama. 2011;305(15):1553\u20139. https:\/\/doi.org\/10.1001\/jama.2011.451.","journal-title":"Jama."},{"issue":"14","key":"1964_CR23","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1002\/sim.6100","volume":"33","author":"G Nattino","year":"2014","unstructured":"Nattino G, Finazzi S, Bertolini G. A new calibration test and a reappraisal of the calibration belt for the assessment of prediction models based on dichotomous outcomes. Stat Med. 2014;33(14):2390\u2013407. https:\/\/doi.org\/10.1002\/sim.6100.","journal-title":"Stat Med"},{"key":"1964_CR24","volume-title":"Stata statistical software: release 16","author":"L StataCorp","year":"2019","unstructured":"StataCorp L. Stata statistical software: release 16. TX: College Station; 2019."},{"issue":"3","key":"1964_CR25","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/nrneph.2017.181","volume":"14","author":"JJ Carrero","year":"2018","unstructured":"Carrero JJ, Hecking M, Chesnaye NC, Jager KJ. Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease. Nat Rev Nephrol. 2018;14(3):151\u201364. https:\/\/doi.org\/10.1038\/nrneph.2017.181.","journal-title":"Nat Rev Nephrol"},{"issue":"9992","key":"1964_CR26","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S0140-6736(14)61842-0","volume":"386","author":"B Shine","year":"2015","unstructured":"Shine B, McKnight RF, Leaver L, Geddes JR. Long-term effects of lithium on renal, thyroid, and parathyroid function: a retrospective analysis of laboratory data. Lancet. 2015;386(9992):461\u20138. https:\/\/doi.org\/10.1016\/S0140-6736(14)61842-0.","journal-title":"Lancet"},{"issue":"11","key":"1964_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002955","volume":"16","author":"RW Major","year":"2019","unstructured":"Major RW, Shepherd D, Medcalf JF, Xu G, Gray LJ, Brunskill NJ. The kidney failure risk equation for prediction of end stage renal disease in UK primary care: an external validation and clinical impact projection cohort study. PLoS Med. 2019;16(11):e1002955. https:\/\/doi.org\/10.1371\/journal.pmed.1002955.","journal-title":"PLoS Med"},{"issue":"12","key":"1964_CR28","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-018483","volume":"7","author":"S-C Weng","year":"2017","unstructured":"Weng S-C, Wu C-L, Kor C-T, Chiu P-F, Wu M-J, Chang C-C, Tarng DC. Migraine and subsequent chronic kidney disease risk: a nationwide population-based cohort study. BMJ Open. 2017;7(12):e018483. https:\/\/doi.org\/10.1136\/bmjopen-2017-018483.","journal-title":"BMJ Open"},{"issue":"1","key":"1964_CR29","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.sjpain.2015.12.002","volume":"11","author":"RJ Leo","year":"2016","unstructured":"Leo RJ, Singh J. Migraine headache and bipolar disorder comorbidity: a systematic review of the literature and clinical implications. Scand J Pain. 2016;11(1):136\u201345. https:\/\/doi.org\/10.1016\/j.sjpain.2015.12.002.","journal-title":"Scand J Pain"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-021-01964-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-021-01964-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-021-01964-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T21:09:44Z","timestamp":1619557784000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-021-01964-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,28]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1964"],"URL":"https:\/\/doi.org\/10.1186\/s12916-021-01964-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.12.31.20248928","asserted-by":"object"}]},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,28]]},"assertion":[{"value":"5 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for this study was obtained from the Independent Scientific Advisory Committee of CPRD (protocol no. 18_316). Informed consent was waived because data are anonymised for research purposes.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"ICKW received research funding from Innovative Medicines Initiative, Shire, Janssen-Cilag, Eli-Lily, Pfizer, Bayer, Amgen outside the submitted work. No other authors declare competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"99"}}